High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH - Cannabis News World

The cannabis company completed the deal for a 51% interest in Remexian for €26.4 million and has a five-year option for the remaining 49% interest.

High Tide Acquires Majority Stake in Remexian Pharma GmbH

CALGARY, AB – High Tide Inc. has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million. The amount will be finalized in 30 days once the final closing balance sheet is available. High Tide will have a five-year option to acquire the remaining 49% of Remexian at any time after 24 months. Transaction details The Transaction implies an enterprise valuation of €53.4 million, representing 3.64065 tim…

High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

Green Stock News for the New Green Economy.